ニュース

最新ニュース

ニュートン・バイオキャピタル、株式会社PRISM BioLabに新規投資

Newton Biocapital invests in PRISM BioLab to support development of a unique peptide mimetic technology platform to discover new drugs for intractable diseases

ニュートン・バイオキャピタル、エディットフォース株式会社に追加投資

Newton Biocapital invests in EditForce to support development of a unique DNA/RNA editing platform based on PPR protein technology

Newton Biocapital invests in NeuVasQ: EUR 20 million Series A to develop unique blood-brain barrier therapy

Acticor Biotech Announces appointment of Mr Alain Munoz as Chairman of the Board of Directors and Mrs Sophie Binay and Mr Yannick Pletan as General Managers.

SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES

Newton Biocapital invests in Flemish start-up DeuterOncology

Newton Biocapital I invests in Perseus Proteomics Inc. in Japan to develop therapeutic antibodies for the treatment of blood cancers

10
11
12
13
14